It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...
1 Day GOOG 3.01% DJIA 1.29% S&P 500 1.56% Technology 3.00% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback